FDA's Breakthrough Therapy Designation and What It Changes for Regulatory Affairs Work
Breakthrough Therapy Designation brings intensive FDA guidance and rolling review, not a lower evidence bar. What it actually changes for regulatory affairs work.
171 articles for regulatory affairs professionals in pharma, biotech and medical devices: career guidance, role profiles, hiring trends and policy explainers. Updated Oct 10, 2026.
5,000+ job seekers
joined our newsletter
Showing 1–4 of 4 articles
Breakthrough Therapy Designation brings intensive FDA guidance and rolling review, not a lower evidence bar. What it actually changes for regulatory affairs work.
The EU's proposed pharmaceutical legislation overhaul could reshape exclusivity, timelines, and labeling. Here's what it means for regulatory affairs work.
Pediatric study requirements in the US and EU are pulling regulatory affairs work in a specialized direction. Here's what that means for hiring and careers.
MHRA's International Recognition Procedure lets the UK lean on trusted overseas regulators to speed up medicine approvals. What it means for regulatory strategy.